A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function
Condition(s) studied
Investigational drug(s) / intervention(s)
Necternal Supplement: All participants will be using the test product as directed. Participants will take 2 stick packs daily, one in the morning and one evening, with 16 oz of water
Placebo: Arm 2 will take a placebo product for the duration of the trial.
Study summary
This is a virtual, two-armed, randomized, triple-blinded, placebo-controlled clinical trial that will last 16 weeks.
Participants will take the supplement or a placebo product twice daily and complete questionnaires at Baseline, 2 weeks, 6 weeks, 12 weeks, and 16 weeks.
Participants will complete cognitive assessments at Baseline, 4 weeks, 8 weeks, and 16 weeks.
Eligibility
Primary outcome measure(s)
- Change in Cognitive Function as Assessed by Polygons — Baseline, 4 weeks, 8 weeks, and 16 weeks
Mean change from baseline in the Polygons test score, assessing processing speed and judgment. Participants will complete a timed, computerized cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment. - Change in Cognitive Function as Assessed by Double Trouble — Baseline, Week 4, Week 8, and Week 16
Mean change from baseline in the Double Trouble test score, assessing selective attention and processing speed. Participants will complete a timed, computerized Stroop-based cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment. - Change in Cognitive Function as Assessed by Feature Match — Baseline, Week 4, Week 8, and Week 16
Mean change from baseline in the Feature Match test score, assessing focus and processing. Participants will complete a timed, computerized cognitive assessment with a duration of 1 minute and 30 seconds. The outcome will be calculated as the mean change in test score from baseline at each follow-up assessment.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Citruslabs | Las Vegas | Nevada |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07883525 on ClinicalTrials.gov ↗ ← All trials in the USA